title: Agranulocytosis secondary to propylthiouracil.
authors.affiliation: Department of Medicine, Johns Hopkins University School of Medicine, 5200 Eastern Avenue, MFL Bldg, West Tower 6th Floor, Baltimore, MD 21224, USA. wkhaliq1@jhmi.edu
authors.forename: W
authors.initials: W
authors.lastname: Khaliq
authors.forename: L
authors.initials: L
authors.lastname: Ponor
authors.forename: P
authors.initials: P
authors.lastname: Cheripalli
authors.forename: K
authors.initials: K
authors.lastname: Tangella
authors.forename: Z
authors.initials: Z
authors.lastname: Chaudhry
mesh_terms: D000328:Adult; D000380:Agranulocytosis / Q000139:chemically induced* / Q000188:drug therapy; D013956:Antithyroid Agents / Q000009:adverse effects*; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D006111:Graves Disease / Q000188:drug therapy*; D006801:Humans; D011441:Propylthiouracil / Q000009:adverse effects*; D016896:Treatment Outcome
chemical_list: D013956:Antithyroid Agents; D016179:Granulocyte Colony-Stimulating Factor; D011441:Propylthiouracil